Rockwell Medical (RMTI) reported a quarterly loss of $0.01 per share, falling short of the Zacks Consensus Estimate of a $0.04 loss. This contrasts with a loss of $0.02 per share reported a year earlier. The company’s revenue for the quarter ending December 2025 was $18.35 million, missing expectations by 1.16% and down from $24.67 million year-over-year.
The earnings surprise was -125.00%, and Rockwell Medical has struggled to surpass consensus EPS estimates over the last four quarters. Despite these setbacks, the company’s shares have increased by approximately 24.8% since the beginning of the year, compared to a 3.7% decline in the S&P 500.
Looking ahead, the consensus EPS estimate for the upcoming quarter is -$0.01 on revenues of $18.7 million, with projected annual revenues of $76.1 million. Currently, Rockwell Medical holds a Zacks Rank of #3 (Hold) within the Medical – Products industry, which is in the bottom 34% of Zacks-ranked industries.
